Literature DB >> 15640824

Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients.

A Abdelkefi1, W Achour, T Ben Othman, L Torjman, S Ladeb, A Lakhal, M Hsaïri, L Kammoun, A Ben Hassen, A Ben Abdeladhim.   

Abstract

Catheter-related bloodstream infections are associated with recognized morbidity and mortality. Accurate diagnosis of such infections results in proper management of patients and in reducing unnecessary removal of catheters. We carried out a prospective study in a bone marrow transplant unit to assess the validity of a test based on the earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for predicting catheter-related bacteremia. Between May 2002 and June 2004, 38 bloodstream infections with positive simultaneous central venous catheter and peripheral vein blood cultures were included. A total of 22 patients had catheter-related bacteremias and 16 had noncatheter-related bacteremias, using the catheter-tip culture/clinical criteria as the criterion standard to define catheter-related bacteremia. Differential time to positivity of 120 min or more was associated with 86% sensitivity and 87% specificity. In conclusion, differential time to positivity of 120 min or more is sensitive and specific for catheter-related bacteremia in hematopoietic stem cell transplant recipients who have nontunnelled short-term catheters.

Entities:  

Mesh:

Year:  2005        PMID: 15640824     DOI: 10.1038/sj.bmt.1704773

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

1.  A comparative assessment of two conservative methods for the diagnosis of catheter-related infection in critically ill patients.

Authors:  John R Gowardman; Paula Jeffries; Melissa Lassig-Smith; Janine Stuart; Paul Jarrett; Renae Deans; Matthew McGrail; Narelle M George; Graeme R Nimmo; Claire M Rickard
Journal:  Intensive Care Med       Date:  2012-09-26       Impact factor: 17.440

Review 2.  Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

Authors:  Dong-Gun Lee; Sung-Han Kim; Soo Young Kim; Chung-Jong Kim; Wan Beom Park; Young Goo Song; Jung-Hyun Choi
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 3.165

Review 3.  Use of rapid diagnostic techniques in ICU patients with infections.

Authors:  Almudena Burillo; Emilio Bouza
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

4.  Retrospective analysis of the safety of peripherally inserted catheters versus implanted port catheters during first-line treatment for patients with diffuse large B-cell lymphoma.

Authors:  Juliette Pénichoux; Julien Rio; Leila Kammoun; Thomas Vermeulin; Louis-Ferdinand Pepin; Vincent Camus; Sydney Dubois; Florian Bouclet; Mustafa Alani; Nathalie Contentin; Stéphane Leprêtre; Aspasia Stamatoullas; Hélène Lanic; Emilie Lemasle; Anne-Lise Ménard; Pascal Lenain; Marie Gilles-Baray; Dragos Georgescu; Florian Clatot; Hervé Tilly; Fabrice Jardin
Journal:  Eur J Haematol       Date:  2022-03-21       Impact factor: 3.674

5.  Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation.

Authors:  Sameeh S Ghazal; Michael P Stevens; Gonzalo M Bearman; Michael B Edmond
Journal:  Antimicrob Resist Infect Control       Date:  2014-06-04       Impact factor: 4.887

6.  Central venous catheter-related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  Boris Böll; Enrico Schalk; Dieter Buchheidt; Justin Hasenkamp; Michael Kiehl; Til Ramon Kiderlen; Matthias Kochanek; Michael Koldehoff; Philippe Kostrewa; Annika Y Claßen; Sibylle C Mellinghoff; Bernd Metzner; Olaf Penack; Markus Ruhnke; Maria J G T Vehreschild; Florian Weissinger; Hans-Heinrich Wolf; Meinolf Karthaus; Marcus Hentrich
Journal:  Ann Hematol       Date:  2020-09-30       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.